Inducible NO synthase and antibacterial host defence in times of Th17/Th22/T22 immunity

Cellular Microbiology

Volumn 13, Issue 3, 2011, Pages 340-348

  Mühl, Heiko ^a   Bachmann, Malte ^a   Pfeilschifter, Josef ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17; INTERLEUKIN 22; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT3 PROTEIN;

BACTERIAL IMMUNITY; BACTERIAL INFECTION; CD4+ T LYMPHOCYTE; CELL CULTURE; DISEASE COURSE; GENE EXPRESSION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL;

ANIMALS; BACTERIAL INFECTIONS; HUMANS; INFLAMMATION; INTERLEUKIN-17; INTERLEUKINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; T-LYMPHOCYTES, HELPER-INDUCER; TH17 CELLS;

EID: 79951471683     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2010.01559.x     Document Type: Review

References (94)

1. Akaike, T., Noguchi, Y., Ijiri, S., Setoguchi, K., Suga, M., Zheng, Y.M., etal. (1996) Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci USA 93: 2448-2453.
2. Alam, M.S., Akaike, T., Okamoto, S., Kubota, T., Yoshitake, J., Sawa, T., etal. (2002) Role of nitric oxide in host defense in murine salmonellosis as a function of its antibacterial and antiapoptotic activities. Infect Immun 70: 3130-3142.
3. Al-Nedawi, K., Meehan, B., Kerbel, R.S., Allison, A.C., and Rak, J. (2009) Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci USA 106: 3794-3799.
4. Ambs, S., Ogunfusika, M.O., Merriam, W.G., Bennett, W.P., Billiar, T.R., and Harris, C.C. (1998) Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Proc Natl Acad Sci USA 95: 8823-8828.
5. Andrew, P.J., Harant, H., and Lindley, I.J. (1995) Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Biochem Biophys Res Commun 214: 949-956.
6. Attur, M.G., Patel, R.N., Abramson, S.B., and Amin, A.R. (1997) Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage. Arthritis Rheum 40: 1050-1053.
7. Aujla, S.J., and Kolls, J.K. (2009) IL-22: a critical mediator in mucosal host defense. J Mol Med 87: 451-454.
8. Aujla, S.J., Chan, Y.R., Zheng, M., Fei, M., Askew, D.J., Pociask, D.A., etal. (2008) IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14: 275-281.
9. Babyatsky, M.W., Rossiter, G., and Podolsky, D.K. (1996) Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 110: 975-984.
10. Bachmann, M., Horn, K., Poleganov, M.A., Paulukat, J., Nold, M., Pfeilschifter, J., and Mühl, H. (2006) Interleukin-18 secretion and Th1-like cytokine responses in human peripheral blood mononuclear cells under the influence of the toll-like receptor-5 ligand flagellin. Cell Microbiol 8: 289-300.
11. Bachmann, M., Horn, K., Rudloff, I., Goren, I., Holdener, M., Christen, U., etal. (2010) Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1. PLoS Pathogens 6: e1001144.
12. Bécherel, P.A., Chosidow, O., Le Goff, L., Francès, C., Debré, P., Mossalayi, M.D., and Arock, M. (1997) Inducible nitric oxide synthase and proinflammatory cytokine expression by human keratinocytes during acute urticaria. Mol Med 3: 686-694.
13. Blaschitz, C., and Raffatellu, M. (2010) Th17 cytokines and the gut mucosal barrier. J Clin Immunol 30: 196-203.
14. Bogdan, C., Röllinghoff, M., and Diefenbach, A. (2000) The role of nitric oxide in innate immunity. Immunol Rev 173: 17-26.
15. Brüne, B., von Knethen, A., and Sandau, K.B. (1999) Nitric oxide (NO): an effector of apoptosis. Cell Death Differ 6: 969-975.
16. Cavicchi, M., and Whittle, B.J. (1999) Potentiation of cytokine induced iNOS expression in the human intestinal epithelial cell line, DLD-1, by cyclic AMP. Gut 45: 367-374.
17. Chiwakata, C.B., Hemmer, C.J., and Dietrich, M. (2000) High levels of inducible nitric oxide synthase mRNA are associated with increased monocyte counts in blood and have a beneficial role in Plasmodium falciparum malaria. Infect Immun 68: 394-399.
18. Cho, J.S., Pietras, E.M., Garcia, N.C., Ramos, R.I., Farzam, D.M., Monroe, H.R., etal. (2010) IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest 120: 1762-1773.
19. Choi, H.S., Rai, P.R., Chu, H.W., Cool, C., and Chan, E.D. (2002) Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis. Am J Respir Crit Care Med 166: 178-186.
20. Colonna, M. (2009) Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31: 15-23.
21. Connelly, L., Palacios-Callender, M., Ameixa, C., Moncada, S., and Hobbs, A.J. (2001) Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. J Immunol 166: 3873-3881.
22. Dandekar, S., George, M.D., and Bäumler, A.J. (2010) Th17 cells, HIV and the gut mucosal barrier. Curr Opin HIV AIDS 5: 173-178.
23. Denis, M. (1994) Human monocytes/macrophages: NO or no NO? J Leukoc Biol 55: 682-684.
24. Dijkstra, G., Moshage, H., van Dullemen, H.M., de Jager-Krikken, A., Tiebosch, A.T., Kleibeuker, J.H., etal. (1998) Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol 186: 416-421.
25. Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A., and Sallusto, F. (2009) Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 10: 857-863.
26. Eberhardt, W., Plüss, C., Hummel, R., and Pfeilschifter, J. (1998) Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells. J Immunol 160: 4961-4969.
27. Enocksson, A., Lundberg, J., Weitzberg, E., Norrby-Teglund, A., and Svenungsson, B. (2004) Rectal nitric oxide gas and stool cytokine levels during the course of infectious gastroenteritis. Clin Diagn Lab Immunol 11: 250-254.
28. Ermert, M., Ruppert, C., Günther, A., Duncker, H.R., Seeger, W., and Ermert, L. (2002) Cell-specific nitric oxide synthase-isoenzyme expression and regulation in response to endotoxin in intact rat lungs. Lab Invest 82: 425-441.
29. Fang, F.C. (2004) Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2: 820-832.
30. Fenton, J.I., and Birmingham, J.M. (2010) Adipokine regulation of colon cancer: adiponectin attenuates interleukin-6-induced colon carcinoma cell proliferation via STAT-3. Mol Carcinog 49: 700-709.
31. Frank, S., Kolb, N., Werner, E.R., and Pfeilschifter, J. (1998) Coordinated induction of inducible nitric oxide synthase and GTP-cyclohydrolase I is dependent on inflammatory cytokines and interferon-gamma in HaCaT keratinocytes: implications for the model of cutaneous wound repair. J Invest Dermatol 111: 1065-1071.
32. Freeswick, P.D., Wan, Y., Geller, D.A., Nussler, A.K., and Billiar, T.R. (1994) Remote tissue injury primes hepatocytes for nitric oxide synthesis. J Surg Res 57: 205-209.
33. Gaffen, S.L. (2008) An overview of IL-17 function and signaling. Cytokine 43: 402-407.
34. Gookin, J.L., Rhoads, J.M., and Argenzio, R.A. (2002) Inducible nitric oxide synthase mediates early epithelial repair of porcine ileum. Am J Physiol Gastrointest Liver Physiol 283: G157-G168.
35. Guo, F.H., De Raeve, H.R., Rice, T.W., Stuehr, D.J., Thunnissen, F.B., and Erzurum, S.C. (1995) Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci USA 92: 7809-7813.
36. Gusarov, I., Shatalin, K., Starodubtseva, M., and Nudler, E. (2009) Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics. Science 325: 1380-1384.
37. Heemskerk, S., Pickkers, P., Bouw, M.P., Draisma, A., van der Hoeven, J.G., Peters, W.H., etal. (2006) Upregulation of renal inducible nitric oxide synthase during human endotoxemia and sepsis is associated with proximal tubule injury. Clin J Am Soc Nephrol 1: 853-862.
38. Hoegl, S., Bachmann, M., Scheiermann, P., Goren, I., Hofstetter, C., Pfeilschifter, J., etal. (2010) Protective properties of inhaled IL-22 in a model of ventilator-induced lung injury. Am J Respir Cell Mol Biol (in press).
39. Ivanov, I.I., Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., etal. (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139: 485-498.
40. Juan, C.C., Lien, C.C., Chang, C.L., Huang, Y.H., and Ho, L.T. (2008) Involvement of iNOS and NO in TNF-alpha-downregulated resistin gene expression in 3T3-L1 adipocytes. Obesity 16: 1219-1225.
41. Kolios, G., Rooney, N., Murphy, C.T., Robertson, D.A., and Westwick, J. (1998) Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines. Gut 43: 56-63.
42. Lander, H.M., Sehajpal, P., Levine, D.M., and Novogrodsky, A. (1993) Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J Immunol 150: 1509-1516.
43. Lane, C., Knight, D., Burgess, S., Franklin, P., Horak, F., Legg, J., etal. (2004) Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath. Thorax 59: 757-760.
44. Levesque, M.C., Hobbs, M.R., Anstey, N.M., Vaughn, T.N., Chancellor, J.A., Pole, A., etal. (1999) Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria. J Infect Dis 180: 1994-2002.
45. Lin, J., Jin, X., Rothman, K., Lin, H.J., Tang, H., and Burke, W. (2002) Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells. Cancer Res 62: 376-380.
46. Llovera, M., Pearson, J.D., Moreno, C., and Riveros-Moreno, V. (2001) Impaired response to interferon-gamma in activated macrophages due to tyrosine nitration of STAT1 by endogenous nitric oxide. Br J Pharmacol 132: 419-426.
47. Lo, H.W. (2010) Nuclear mode of the EGFR signaling network: biology, prognostic value, and therapeutic implications. Discov Med 10: 44-51.
48. Lo, H.W., Hsu, S.C., Ali-Seyed, M., Gunduz, M., Xia, W., Wei, Y., etal. (2005) Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 7: 575-589.
49. Louten, J., Boniface, K., and de Waal Malefyt, R. (2009) Development and function of TH17 cells in health and disease. J Allergy Clin Immunol 123: 1004-1011.
50. McCafferty, D.M., Mudgett, J.S., Swain, M.G., and Kubes, P. (1997) Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 112: 1022-1027.
51. McInnes, I.B., Leung, B., Wei, X.Q., Gemmell, C.C., and Liew, F.Y. (1998) Septic arthritis following Staphylococcus aureus infection in mice lacking inducible nitric oxide synthase. J Immunol 160: 308-315.
52. Martel-Pelletier, J., Mineau, F., Jovanovic, D., Di Battista, J.A., and Pelletier, J.P. (1999) Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated proten kinase (MAPKAPK). Arthritis Rheum 42: 2399-2409.
53. Mastroeni, P., Vazquez-Torres, A., Fang, F.C., Xu, Y., Khan, S., Hormaeche, C.E., and Dougan, G. (2000) Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J Exp Med 192: 237-248.
54. Miljkovic, D., and Trajkovic, V. (2004) Inducible nitric oxide synthase activation by interleukin-17. Cytokine Growth Factor Rev 15: 21-32.
55. Miossec, P., Korn, T., and Kuchroo, V.K. (2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361: 888-898.
56. Mühl, H., and Pfeilschifter, J. (1995) Amplification of nitric oxide synthase expression by nitric oxide in interleukin 1 beta-stimulated rat mesangial cells. J Clin Invest 95: 1941-1946.
57. Mühl, H., Kunz, D., and Pfeilschifter, J. (1994) Expression of nitric oxide synthase in rat glomerular mesangial cells mediated by cyclic AMP. Br J Pharmacol 112: 1-8.
58. Mühl, H., Chang, J.H., Huwiler, A., Bosmann, M., Paulukat, J., Ninic, R., etal. (2000) Nitric oxide augments release of chemokines from monocytic U937 cells: modulation by anti-inflammatory pathways. Free Radic Biol Med 29: 969-980.
59. Nathan, C., and Shiloh, M.U. (2000) Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 97: 8841-8848.
60. Niu, G., Wright, K.L., Ma, Y., Wright, G.M., Huang, M., Irby, R., etal. (2005) Role of Stat3 in regulating p53 expression and function. Mol Cell Biol 25: 7432-7440.
61. Nograles, K.E., Zaba, L.C., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Kikuchi, T., etal. (2009) IL-22-producing 'T22' T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 123: 1244-1252.
62. O'Connor, W., Jr, Zenewicz, L.A., and Flavell, R.A. (2010) The dual nature of T(H)17 cells: shifting the focus to function. Nat Immunol 11: 471-476.
63. Oliver, B.L., Cronin, C.G., Zhang-Benoit, Y., Goldring, M.B., and Tanzer, M.L. (2005) Divergent stress responses to IL-1beta, nitric oxide, and tunicamycin by chondrocytes. J Cell Physiol 204: 45-50.
64. Osna, N.A., Clemens, D.L., and Donohue, T.M., Jr (2005) Ethanol metabolism alters interferon gamma signaling in recombinant HepG2 cells. Hepatology 42: 1109-1117.
65. Park, S.Y., Cho, J.H., Ma, W., Choi, H.J., and Han, J.S. (2010) Phospholipase D2 acts as an important regulator in LPS-induced nitric oxide synthesis in Raw 264.7 cells. Cell Signal 22: 619-628.
66. Pastore, S., Mascia, F., Mariani, V., and Girolomoni, G. (2008) The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol 128: 1365-1374.
67. Pautz, A., Art, J., Hahn, S., Nowag, S., Voss, C., and Kleinert, H. (2010) Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide 23: 75-93.
68. Peng, H.B., Spiecker, M., and Liao, J.K. (1998) Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J Immunol 161: 1970-1976.
69. Pérez-Sala, D., Cernuda-Morollón, E., Díaz-Cazorla, M., Rodríguez-Pascual, F., and Lamas, S. (2001) Posttranscriptional regulation of human iNOS by the NO/cGMP pathway. Am J Physiol Renal Physiol 280: F466-F473.
70. Pfeilschifter, J., Kunz, D., and Mühl, H. (1993) Nitric oxide: an inflammatory mediator of glomerular mesangial cells. Nephron 64: 518-525.
71. Pickert, G., Neufert, C., Leppkes, M., Zheng, Y., Wittkopf, N., Warntjen, M., etal. (2009) STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 206: 1465-1472.
72. Qadoumi, M., Becker, I., Donhauser, N., Röllinghoff, M., and Bogdan, C. (2002) Expression of inducible nitric oxide synthase in skin lesions of patients with american cutaneous leishmaniasis. Infect Immun 70: 4638-4642.
73. Radaeva, S., Sun, R., Pan, H.N., Hong, F., and Gao, B. (2004) Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39: 1332-1342.
74. Raffatellu, M., Santos, R.L., Verhoeven, D.E., George, M.D., Wilson, R.P., Winter, S.E., etal. (2008) Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 14: 421-428.
75. Raffatellu, M., George, M.D., Akiyama, Y., Hornsby, M.J., Nuccio, S.P., Paixao, T.A., etal. (2009) Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 5: 476-486.
76. Richardson, A.R., Soliven, K.C., Castor, M.E., Barnes, P.D., Libby, S.J., and Fang, F.C. (2009) The Base Excision Repair system of Salmonella enterica serovar typhimurium counteracts DNA damage by host nitric oxide. PLoS Pathog 5: e1000451.
77. Santos, R.L., Raffatellu, M., Bevins, C.L., Adams, L.G., Tükel, C., Tsolis, R.M., and Bäumler, A.J. (2009) Life in the inflamed intestine, Salmonella style. Trends Microbiol 17: 498-506.
78. Sasaki, S., Miura, T., Nishikawa, S., Yamada, K., Hirasue, M., and Nakane, A. (1998) Protective role of nitric oxide in Staphylococcus aureus infection in mice. Infect Immun 66: 1017-1022.
79. Schleimer, R.P., Kato, A., Kern, R., Kuperman, D., and Avila, P.C. (2007) Epithelium: at the interface of innate and adaptive immune responses. J Allergy Clin Immunol 120: 1279-1284.
80. Schmidt, N., Pautz, A., Art, J., Rauschkolb, P., Jung, M., Erkel, G., etal. (2010) Transcriptional and post-transcriptional regulation of iNOS expression in human chondrocytes. Biochem Pharmacol 79: 722-732.
81. Schulz, S.M., Köhler, G., Schütze, N., Knauer, J., Straubinger, R.K., Chackerian, A.A., etal. (2008) Protective immunity to systemic infection with attenuated Salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17. J Immunol 181: 7891-7901.
82. Shalom-Barak, T., Quach, J., and Lotz, M. (1998) Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem 273: 27467-27473.
83. Sheffler, L.A., Wink, D.A., Melillo, G., and Cox, G.W. (1995) Exogenous nitric oxide regulates IFN-gamma plus lipopolysaccharide-induced nitric oxide synthase expression in mouse macrophages. J Immunol 155: 886-894.
84. Sherman, P.A., Laubach, V.E., Reep, B.R., and Wood, E.R. (1993) Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry 32: 11600-11605.
85. Tsai, W.C., Strieter, R.M., Zisman, D.A., Wilkowski, J.M., Bucknell, K.A., Chen, G.H., and Standiford, T.J. (1997) Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae. Infect Immun 65: 1870-1875.
86. Vallance, B.A., Deng, W., De Grado, M., Chan, C., Jacobson, K., and Finlay, B.B. (2002) Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen Citrobacter rodentium in infected mice. Infect Immun 70: 6424-6435.
87. van de Veerdonk, F.L., Gresnigt, M.S., Kullberg, B.J., van der Meer, J.W., Joosten, L.A., and Netea, M.G. (2009) Th17 responses and host defense against microorganisms: an overview. BMB Rep 42: 776-787.
88. Walpen, S., Beck, K.F., Schaefer, L., Raslik, I., Eberhardt, W., Schaefer, R.M., and Pfeilschifter, J. (2001) Nitric oxide induces MIP-2 transcription in rat renal mesangial cells and in a rat model of glomerulonephritis. FASEB J 15: 571-573.
89. Ward, C., Dransfield, I., Chilvers, E.R., Haslett, C., and Rossi, A.G. (1999) Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. Trends Pharmacol Sci 20: 503-509.
90. Wolk, K., Witte, E., Witte, K., Warszawska, K., and Sabat, R. (2010) Biology of interleukin-22. Semin Immunopathol 32: 17-31.
91. Xie, Q.W., Whisnant, R., and Nathan, C. (1993) Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med 177: 1779-1784.
92. Yeo, T.W., Lampah, D.A., Tjitra, E., Gitawati, R., Darcy, C.J., Jones, C., etal. (2010) Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcome. PLoS Pathog 6: e1000868.
93. Yu, X., Kennedy, R.H., and Liu, S.J. (2003) JAK2/STAT3, not ERK1/2, mediates interleukin-6-induced activation of inducible nitric-oxide synthase and decrease in contractility of adult ventricular myocytes. J Biol Chem 278: 16304-16309.
94. Ziesché, E., Bachmann, M., Kleinert, H., Pfeilschifter, J., and Mühl, H. (2007) The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells. J Biol Chem 282: 16006-16015.